$1.740
-0.067 (-3.87%)終値時点
- High
- 1.820
- Open
- 1.810
- VWAP
- 1.73
- Vol
- 285.52K
- Mkt Cap
- 49.43M
- Low
- 1.620
- Amount
- 493.00K
- EV/EBITDA, TTM
- 0.00
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
バリュエーション指標
イベントタイムライン
ニュース
8.511-20GlobenewswireXOMA Royalty Completes Acquisition of LAVA Therapeutics N.V.
8.511-13NewsfilterLAVA Reports Surpassing Minimum Requirement in Tender Offer and Plans to Withdraw from Nasdaq
7.010-20PRnewswireShareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement
8.510-17GlobenewswireXOMA Royalty and LAVA Therapeutics Reveal Changes to Purchase Agreement
- 8.510-02Newsfilter
XOMA Royalty Prolongs Tender Offer to Purchase LAVA Therapeutics N.V.
LVTX FAQ — answered by Alphio AI
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer. It operates in the Healthcare sector.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。